New paper below [1].
"Results from the ERA 223 trial of abiraterone combined with radium-223 among men with chemotherapy-naïve castration-resistant prostate cancer and bone metastases show no improvement in survival free from symptomatic skeletal events. We hypothesize that this finding might be attributable to bone loss induced by the concomitantly administered prednisone."
From 2010 [2] - a dog experiment:
"All animals received prednisone orally at a dose of 2 mg/kg of weight for 30 days" - resulting in "a loss of bone mass of approximately 14%".
In another 2010 non-PCa paper from the Netherlands [3]:
"High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use."
-Patrick
[1] ncbi.nlm.nih.gov/pubmed/307...